Friday, July 10, 2026

pharma · Pulmonary Hypertension Associated with Interstitial Lung Disease · Pulmonary Arterial Hypertension

Insmed Incorporated

Insmed Incorporated trial registry — 7 ClinicalTrials.gov studies with program phase, status, and indication context.

Bridgewater Township, USA HQ
1,666 Employees
EMA registrant Type
Company details
Status
Public
HQ
Bridgewater Township, USA
Employees
1,666
Programs
7
Drugs
18
Patents
0
Intelligence · Clinical Trials

Insmed Incorporated clinical trials

Registry index of 7 ClinicalTrials.gov studies linked to Insmed Incorporated programs — each row shows trial ID, program name, phase, status, and indication.

Insmed Incorporated trial registry — 7 ClinicalTrials.gov studies with program phase, status, and indication context.

Recent trial activity

7 updates

Latest clinical program signals indexed for Insmed Incorporated.

  1. The BiRCh Study — Phase 2

    Clinical update
  2. INS1009-212 — Phase 3

    Clinical update
  3. INS-416 — Phase 3

    Clinical update
  4. INS1009-311 — Phase 3

    Clinical update
  5. INS1009-203 — Phase 3

    Clinical update
  6. INS1009-202 — Phase 2

    Clinical update
  7. INS1007-231 — Phase 2

    Clinical update

Trial registry

7 studies
  1. 2023-505273-33-00

    INS-416

    Phase 3 active small_molecule

    "Adult Subjects with Newly Diagnosed Nontuberculous Mycobacterial (NTM) Lung Infection Caused by Mycobacterium avium Complex (MAC)"

    CTIS ↗